ホスホリラーゼ

阻害剤の選択性比較

カタログ番号 製品カタログ 溶解度(25°C)
DMSO アルコール
S2717 CP-91149 <1 mg/mL 80 mg/mL <1 mg/mL
S6510 Iso-H7 dihydrochloride 73 mg/mL 73 mg/mL 73 mg/mL
S3731 Tipiracil hydrochloride 55 mg/mL 8 mg/mL <1 mg/mL
S2045 Doxifluridine 49 mg/mL 49 mg/mL <1 mg/mL

Phosphorylase製品

新Phosphorylase製品
製品コード 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S2717

CP-91149

CP-91149 is a selective glycogen phosphorylase (GP) inhibitor with IC50 of 0.13 μM in the presence of glucose, 5- to 10-fold less potent in the absence of glucose.

S6510

Iso-H7 dihydrochloride

S3731

Tipiracil hydrochloride

Tipiracil is an inhibitor of thymidine phosphorylase, the enzyme that degrades trifluridine into trifluorothymidine. Its combination with trifluridine increases the bioavailability of trifluridine.

S2045

Doxifluridine

Doxifluridine is an oral prodrug that is converted to the cytotoxic agent 5-fluorouracil (5-FU).

製品コード 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S2717

CP-91149

CP-91149 is a selective glycogen phosphorylase (GP) inhibitor with IC50 of 0.13 μM in the presence of glucose, 5- to 10-fold less potent in the absence of glucose.

S6510

Iso-H7 dihydrochloride

S3731

Tipiracil hydrochloride

Tipiracil is an inhibitor of thymidine phosphorylase, the enzyme that degrades trifluridine into trifluorothymidine. Its combination with trifluridine increases the bioavailability of trifluridine.

製品コード 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S2045

Doxifluridine

Doxifluridine is an oral prodrug that is converted to the cytotoxic agent 5-fluorouracil (5-FU).

2019, 29(5):1217-1231

2018, Oncotarget